Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
6.40
Oct 23 • 3:59 PM ET Dollar change+0.03 Percentage change(0.47%)
Aftermarket Close
6.48
Aftermarket • 7:54 PM ET Dollar change+0.08 Percentage change(1.20%)
Index
RUT
Market Cap
242.62M
Enterprise Value
431.95M
Income
-
Sales
-
Book/sh
-0.90
Cash/sh
0.45
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
-
IPO
Feb 15, 1996
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
14.07
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
2.69
Current Ratio
3.87
Debt/Eq
9.72
LT Debt/Eq
9.64
Option/Short
Yes / Yes
EPS (ttm)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
31.55% 0.55%
Sales past 3/5Y
5.02% -26.24%
EPS Y/Y TTM
-430.88%
Sales Y/Y TTM
-
EPS Q/Q
-243.04%
Sales Q/Q
-6.25%
Insider Own
9.60%
Insider Trans
0.00%
Inst Own
75.56%
Inst Trans
-0.06%
ROA
-
ROE
-
ROIC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-0.81%
SMA50
22.41%
SMA200
15.51%
Trades
Shs Outstand
37.70M
Shs Float
34.27M
52W High
8.98 -28.73%
52W Low
3.62 76.55%
Volatility
0.55% 1.19%
ATR (14)
0.13
RSI (14)
71.31
Beta
0.99
Rel Volume
0.66
Avg Volume
339.72K
Volume
224,041
Perf Week
0.31%
Perf Month
49.18%
Perf Quarter
47.47%
Perf Half Y
27.49%
Perf YTD
-21.76%
Perf Year
-6.02%
Perf 3Y
-11.85%
Perf 5Y
-32.63%
Perf 10Y
-54.12%
Prev Close
6.37
Price
6.40
Change %
0.47%
Date Action Analyst Rating Change Price Target Change
Mar-17-26Upgrade Barrington Research Mkt Perform → Outperform $5.50
Sep-04-25Initiated KeyBanc Capital Markets Sector Weight
May-21-25Initiated William Blair Outperform
Sep-05-24Initiated Craig Hallum Buy $8
Aug-28-24Downgrade Barrington Research Outperform → Mkt Perform
Mar-20-23Downgrade Stephens Overweight → Equal-Weight $11 → $2
Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The company was founded by Otto Sartorius in 1965 and is headquartered in Chaska, MN.
PresidentMr. Paul Josephs
Executive VP & CFOMr. Ryan D. Lake CPA
Chief Legal & Administration Officer and Corporate SecretaryMr. Thomas D. Salus
Vice President of OperationsMr. Thomas Guldager
Director of Internal Audit & Chief Compliance OfficerMr. Aaron Perlitsh